BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10557042)

  • 21. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia].
    Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
    J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
    Seeger K; Kreuzer KA; Lass U; Taube T; Buchwald D; Eckert C; Körner G; Schmidt CA; Henze G
    Cancer Res; 2001 Mar; 61(6):2517-22. PubMed ID: 11289124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TEL/AML1 positivity in childhood ALL: average or better prognosis? Czech Paediatric Haematology Working Group.
    Zuna J; Hrusák O; Kalinová M; Muzíková K; Starý J; Trka J
    Leukemia; 1999 Jan; 13(1):22-4. PubMed ID: 10049055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
    Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
    Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of the TEL-AML1 fusion gene in pediatric acute lymphoblastic leukemia in Turkey.
    Ozbek U; Sirma S; Agaoglu L; Yuksel L; Anak S; Yildiz I; Devecioglu O; Timur C; Meral A; Gedikoglu G
    J Pediatr Hematol Oncol; 2003 Mar; 25(3):204-8. PubMed ID: 12621238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TEL/AML-1 fusion gene. its frequency and prognostic significance in childhood acute lymphoblastic leukemia.
    Jamil A; Theil KS; Kahwash S; Ruymann FB; Klopfenstein KJ
    Cancer Genet Cytogenet; 2000 Oct; 122(2):73-8. PubMed ID: 11106814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia.
    Drunat S; Olivi M; Brunie G; Grandchamp B; Vilmer E; Bièche I; Cavé H
    Br J Haematol; 2001 Aug; 114(2):281-9. PubMed ID: 11529845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
    Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
    Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California.
    McHale CM; Wiemels JL; Zhang L; Ma X; Buffler PA; Guo W; Loh ML; Smith MT
    Genes Chromosomes Cancer; 2003 May; 37(1):36-43. PubMed ID: 12661004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia.
    de Haas V; Oosten L; Dee R; Verhagen OJ; Kroes W; van den Berg H; van der Schoot CE
    Br J Haematol; 2000 Dec; 111(4):1080-6. PubMed ID: 11167743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
    Schmidt K; Seeger K; Scheibenbogen C; Bender R; Abdulla M; Süssmilch S; Salama A; Moldenhauer A
    J Leukoc Biol; 2009 Mar; 85(3):563-73. PubMed ID: 19129484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukemia predicts TEL-AML1 negativity. The Pediatric Hematology Working Group in the Czech Republic.
    Hrusák O; Trka J; Zuna J; Housková J; Bartůnková J; Starý J
    Leukemia; 1998 Jul; 12(7):1064-70. PubMed ID: 9665191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.
    Ramakers-van Woerden NL; Pieters R; Loonen AH; Hubeek I; van Drunen E; Beverloo HB; Slater RM; Harbott J; Seyfarth J; van Wering ER; Hählen K; Schmiegelow K; Janka-Schaub GE; Veerman AJ
    Blood; 2000 Aug; 96(3):1094-9. PubMed ID: 10910927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.
    Pine SR; Wiemels JL; Jayabose S; Sandoval C
    Leuk Res; 2003 Feb; 27(2):155-64. PubMed ID: 12526921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Holleman A; Appel IM; Beverloo HB; van Wering ER; Janka-Schaub GE; Evans WE; Pieters R
    Blood; 2005 Jun; 105(11):4223-5. PubMed ID: 15718422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.